Global Dendritic Cell Cancer Vaccine Sales Market Report 2016

December 2016 | 114 pages | ID: G503BFAF52DEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Aseptic Packaging for the Pharmaceutical

Revenue, means the sales value of Aseptic Packaging for the Pharmaceutical

This report studies sales (consumption) of Dendritic Cell Cancer Vaccine in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• 3M Company
• Activartis
• Batavia Bioservices
• Creagene
• Dendreon
• Merck
• Northwest Biotherapeutics
• Glaxo Smith Kline
• ImmunoCellular Therapeutics
• Tella Incorporation

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Dendritic Cell Cancer Vaccine in these regions, from 2011 to 2021 (forecast), like

• United States
• China
• Europe
• Japan

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

• CreaVax
• Dendritic Cell Activated Cytokine Induced Killer Cells (DC-CIK)
• Provenge

Split by applications, this report focuses on sales, market share and growth rate of Dendritic Cell Cancer Vaccine in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Dendritic Cell Cancer Vaccine Sales Market Report 2016

1 DENDRITIC CELL CANCER VACCINE OVERVIEW

1.1 Product Overview and Scope of Dendritic Cell Cancer Vaccine
1.2 Classification of Dendritic Cell Cancer Vaccine
  1.2.11 CreaVax
  1.2.12 Dendritic Cell Activated Cytokine Induced Killer Cells (DC-CIK)
  1.2.13 Provenge
1.3 Application of Dendritic Cell Cancer Vaccine
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Dendritic Cell Cancer Vaccine Market by Regions
  1.4.1 United States Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Dendritic Cell Cancer Vaccine (2011-2021)
  1.5.1 Global Dendritic Cell Cancer Vaccine Sales and Growth Rate (2011-2021)
  1.5.2 Global Dendritic Cell Cancer Vaccine Revenue and Growth Rate (2011-2021)

2 GLOBAL DENDRITIC CELL CANCER VACCINE COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Dendritic Cell Cancer Vaccine Market Competition by Manufacturers
  2.1.1 Global Dendritic Cell Cancer Vaccine Sales and Market Share of Key Manufacturers (2011-2016)
  2.1.2 Global Dendritic Cell Cancer Vaccine Revenue and Share by Manufacturers (2011-2016)
2.2 Global Dendritic Cell Cancer Vaccine (Volume and Value) by Type
  2.2.1 Global Dendritic Cell Cancer Vaccine Sales and Market Share by Type (2011-2016)
  2.2.2 Global Dendritic Cell Cancer Vaccine Revenue and Market Share by Type (2011-2016)
2.3 Global Dendritic Cell Cancer Vaccine (Volume and Value) by Regions
  2.3.1 Global Dendritic Cell Cancer Vaccine Sales and Market Share by Regions (2011-2016)
  2.3.2 Global Dendritic Cell Cancer Vaccine Revenue and Market Share by Regions (2011-2016)
2.4 Global Dendritic Cell Cancer Vaccine (Volume) by Application

3 UNITED STATES DENDRITIC CELL CANCER VACCINE (VOLUME, VALUE AND SALES PRICE)

3.1 United States Dendritic Cell Cancer Vaccine Sales and Value (2011-2016)
  3.1.1 United States Dendritic Cell Cancer Vaccine Sales and Growth Rate (2011-2016)
  3.1.2 United States Dendritic Cell Cancer Vaccine Revenue and Growth Rate (2011-2016)
  3.1.3 United States Dendritic Cell Cancer Vaccine Sales Price Trend (2011-2016)
3.2 United States Dendritic Cell Cancer Vaccine Sales and Market Share by Manufacturers
3.3 United States Dendritic Cell Cancer Vaccine Sales and Market Share by Type
3.4 United States Dendritic Cell Cancer Vaccine Sales and Market Share by Application

4 CHINA DENDRITIC CELL CANCER VACCINE (VOLUME, VALUE AND SALES PRICE)

4.1 China Dendritic Cell Cancer Vaccine Sales and Value (2011-2016)
  4.1.1 China Dendritic Cell Cancer Vaccine Sales and Growth Rate (2011-2016)
  4.1.2 China Dendritic Cell Cancer Vaccine Revenue and Growth Rate (2011-2016)
  4.1.3 China Dendritic Cell Cancer Vaccine Sales Price Trend (2011-2016)
4.2 China Dendritic Cell Cancer Vaccine Sales and Market Share by Manufacturers
4.3 China Dendritic Cell Cancer Vaccine Sales and Market Share by Type
4.4 China Dendritic Cell Cancer Vaccine Sales and Market Share by Application

5 EUROPE DENDRITIC CELL CANCER VACCINE (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Dendritic Cell Cancer Vaccine Sales and Value (2011-2016)
  5.1.1 Europe Dendritic Cell Cancer Vaccine Sales and Growth Rate (2011-2016)
  5.1.2 Europe Dendritic Cell Cancer Vaccine Revenue and Growth Rate (2011-2016)
  5.1.3 Europe Dendritic Cell Cancer Vaccine Sales Price Trend (2011-2016)
5.2 Europe Dendritic Cell Cancer Vaccine Sales and Market Share by Manufacturers
5.3 Europe Dendritic Cell Cancer Vaccine Sales and Market Share by Type
5.4 Europe Dendritic Cell Cancer Vaccine Sales and Market Share by Application

6 JAPAN DENDRITIC CELL CANCER VACCINE (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Dendritic Cell Cancer Vaccine Sales and Value (2011-2016)
  6.1.1 Japan Dendritic Cell Cancer Vaccine Sales and Growth Rate (2011-2016)
  6.1.2 Japan Dendritic Cell Cancer Vaccine Revenue and Growth Rate (2011-2016)
  6.1.3 Japan Dendritic Cell Cancer Vaccine Sales Price Trend (2011-2016)
6.2 Japan Dendritic Cell Cancer Vaccine Sales and Market Share by Manufacturers
6.3 Japan Dendritic Cell Cancer Vaccine Sales and Market Share by Type
6.4 Japan Dendritic Cell Cancer Vaccine Sales and Market Share by Application

7 GLOBAL DENDRITIC CELL CANCER VACCINE MANUFACTURERS ANALYSIS

7.1 3M Company
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Dendritic Cell Cancer Vaccine Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 3M Company Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  7.1.4 Main Business/Business Overview
7.2 Activartis
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 114 Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Activartis Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  7.2.4 Main Business/Business Overview
7.3 Batavia Bioservices
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 119 Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Batavia Bioservices Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  7.3.4 Main Business/Business Overview
7.4 Creagene
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Dec Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Creagene Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  7.4.4 Main Business/Business Overview
7.5 Dendreon
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Dendreon Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  7.5.4 Main Business/Business Overview
7.6 Merck
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Million USD Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Merck Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  7.6.4 Main Business/Business Overview
7.7 Northwest Biotherapeutics
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Pharma & Healthcare Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  7.7.4 Main Business/Business Overview
7.8 Glaxo Smith Kline
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Glaxo Smith Kline Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  7.8.4 Main Business/Business Overview
7.9 ImmunoCellular Therapeutics
  7.9.1 Company Basic Information, Manufacturing Base and Competitors
  7.9.2 Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  7.9.4 Main Business/Business Overview
7.10 Tella Incorporation
  7.10.1 Company Basic Information, Manufacturing Base and Competitors
  7.10.2 Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 Tella Incorporation Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  7.10.4 Main Business/Business Overview

8 DENDRITIC CELL CANCER VACCINE MAUFACTURING COST ANALYSIS

8.1 Dendritic Cell Cancer Vaccine Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Process Analysis of Dendritic Cell Cancer Vaccine

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Dendritic Cell Cancer Vaccine Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Dendritic Cell Cancer Vaccine Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL DENDRITIC CELL CANCER VACCINE MARKET FORECAST (2016-2021)

12.1 Global Dendritic Cell Cancer Vaccine Sales, Revenue Forecast (2016-2021)
12.2 Global Dendritic Cell Cancer Vaccine Sales Forecast by Regions (2016-2021)
12.3 Global Dendritic Cell Cancer Vaccine Sales Forecast by Type (2016-2021)
12.4 Global Dendritic Cell Cancer Vaccine Sales Forecast by Application (2016-2021)

13 APPENDIX

Disclosure Section
Research Methodology
Data Source
China Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Dendritic Cell Cancer Vaccine
Table Classification of Dendritic Cell Cancer Vaccine
Figure Global Sales Market Share of Dendritic Cell Cancer Vaccine by Type in 2015
Figure CreaVax Picture
Figure Dendritic Cell Activated Cytokine Induced Killer Cells (DC-CIK) Picture
Figure Provenge Picture
Table Applications of Dendritic Cell Cancer Vaccine
Figure Global Sales Market Share of Dendritic Cell Cancer Vaccine by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure United States Dendritic Cell Cancer Vaccine Revenue and Growth Rate (2011-2021)
Figure China Dendritic Cell Cancer Vaccine Revenue and Growth Rate (2011-2021)
Figure Europe Dendritic Cell Cancer Vaccine Revenue and Growth Rate (2011-2021)
Figure Japan Dendritic Cell Cancer Vaccine Revenue and Growth Rate (2011-2021)
Figure Global Dendritic Cell Cancer Vaccine Sales and Growth Rate (2011-2021)
Figure Global Dendritic Cell Cancer Vaccine Revenue and Growth Rate (2011-2021)
Table Global Dendritic Cell Cancer Vaccine Sales of Key Manufacturers (2011-2016)
Table Global Dendritic Cell Cancer Vaccine Sales Share by Manufacturers (2011-2016)
Figure 2015 Dendritic Cell Cancer Vaccine Sales Share by Manufacturers
Figure 2016 Dendritic Cell Cancer Vaccine Sales Share by Manufacturers
Table Global Dendritic Cell Cancer Vaccine Revenue by Manufacturers (2011-2016)
Table Global Dendritic Cell Cancer Vaccine Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Dendritic Cell Cancer Vaccine Revenue Share by Manufacturers
Table 2016 Global Dendritic Cell Cancer Vaccine Revenue Share by Manufacturers
Table Global Dendritic Cell Cancer Vaccine Sales and Market Share by Type (2011-2016)
Table Global Dendritic Cell Cancer Vaccine Sales Share by Type (2011-2016)
Figure Sales Market Share of Dendritic Cell Cancer Vaccine by Type (2011-2016)
Figure Global Dendritic Cell Cancer Vaccine Sales Growth Rate by Type (2011-2016)
Table Global Dendritic Cell Cancer Vaccine Revenue and Market Share by Type (2011-2016)
Table Global Dendritic Cell Cancer Vaccine Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Dendritic Cell Cancer Vaccine by Type (2011-2016)
Figure Global Dendritic Cell Cancer Vaccine Revenue Growth Rate by Type (2011-2016)
Table Global Dendritic Cell Cancer Vaccine Sales and Market Share by Regions (2011-2016)
Table Global Dendritic Cell Cancer Vaccine Sales Share by Regions (2011-2016)
Figure Sales Market Share of Dendritic Cell Cancer Vaccine by Regions (2011-2016)
Figure Global Dendritic Cell Cancer Vaccine Sales Growth Rate by Regions (2011-2016)
Table Global Dendritic Cell Cancer Vaccine Revenue and Market Share by Regions (2011-2016)
Table Global Dendritic Cell Cancer Vaccine Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Dendritic Cell Cancer Vaccine by Regions (2011-2016)
Figure Global Dendritic Cell Cancer Vaccine Revenue Growth Rate by Regions (2011-2016)
Table Global Dendritic Cell Cancer Vaccine Sales and Market Share by Application (2011-2016)
Table Global Dendritic Cell Cancer Vaccine Sales Share by Application (2011-2016)
Figure Sales Market Share of Dendritic Cell Cancer Vaccine by Application (2011-2016)
Figure Global Dendritic Cell Cancer Vaccine Sales Growth Rate by Application (2011-2016)
Figure United States Dendritic Cell Cancer Vaccine Sales and Growth Rate (2011-2016)
Figure United States Dendritic Cell Cancer Vaccine Revenue and Growth Rate (2011-2016)
Figure United States Dendritic Cell Cancer Vaccine Sales Price Trend (2011-2016)
Table United States Dendritic Cell Cancer Vaccine Sales by Manufacturers (2011-2016)
Table United States Dendritic Cell Cancer Vaccine Market Share by Manufacturers (2011-2016)
Table United States Dendritic Cell Cancer Vaccine Sales by Type (2011-2016)
Table United States Dendritic Cell Cancer Vaccine Market Share by Type (2011-2016)
Table United States Dendritic Cell Cancer Vaccine Sales by Application (2011-2016)
Table United States Dendritic Cell Cancer Vaccine Market Share by Application (2011-2016)
Figure China Dendritic Cell Cancer Vaccine Sales and Growth Rate (2011-2016)
Figure China Dendritic Cell Cancer Vaccine Revenue and Growth Rate (2011-2016)
Figure China Dendritic Cell Cancer Vaccine Sales Price Trend (2011-2016)
Table China Dendritic Cell Cancer Vaccine Sales by Manufacturers (2011-2016)
Table China Dendritic Cell Cancer Vaccine Market Share by Manufacturers (2011-2016)
Table China Dendritic Cell Cancer Vaccine Sales by Type (2011-2016)
Table China Dendritic Cell Cancer Vaccine Market Share by Type (2011-2016)
Table China Dendritic Cell Cancer Vaccine Sales by Application (2011-2016)
Table China Dendritic Cell Cancer Vaccine Market Share by Application (2011-2016)
Figure Europe Dendritic Cell Cancer Vaccine Sales and Growth Rate (2011-2016)
Figure Europe Dendritic Cell Cancer Vaccine Revenue and Growth Rate (2011-2016)
Figure Europe Dendritic Cell Cancer Vaccine Sales Price Trend (2011-2016)
Table Europe Dendritic Cell Cancer Vaccine Sales by Manufacturers (2011-2016)
Table Europe Dendritic Cell Cancer Vaccine Market Share by Manufacturers (2011-2016)
Table Europe Dendritic Cell Cancer Vaccine Sales by Type (2011-2016)
Table Europe Dendritic Cell Cancer Vaccine Market Share by Type (2011-2016)
Table Europe Dendritic Cell Cancer Vaccine Sales by Application (2011-2016)
Table Europe Dendritic Cell Cancer Vaccine Market Share by Application (2011-2016)
Figure Japan Dendritic Cell Cancer Vaccine Sales and Growth Rate (2011-2016)
Figure Japan Dendritic Cell Cancer Vaccine Revenue and Growth Rate (2011-2016)
Figure Japan Dendritic Cell Cancer Vaccine Sales Price Trend (2011-2016)
Table Japan Dendritic Cell Cancer Vaccine Sales by Manufacturers (2011-2016)
Table Japan Dendritic Cell Cancer Vaccine Market Share by Manufacturers (2011-2016)
Table Japan Dendritic Cell Cancer Vaccine Sales by Type (2011-2016)
Table Japan Dendritic Cell Cancer Vaccine Market Share by Type (2011-2016)
Table Japan Dendritic Cell Cancer Vaccine Sales by Application (2011-2016)
Table Japan Dendritic Cell Cancer Vaccine Market Share by Application (2011-2016)
Table 3M Company Basic Information List
Table 3M Company Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Figure 3M Company Dendritic Cell Cancer Vaccine Global Market Share (2011-2016)
Table Activartis Basic Information List
Table Activartis Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Activartis Dendritic Cell Cancer Vaccine Global Market Share (2011-2016)
Table Batavia Bioservices Basic Information List
Table Batavia Bioservices Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Batavia Bioservices Dendritic Cell Cancer Vaccine Global Market Share (2011-2016)
Table Creagene Basic Information List
Table Creagene Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Creagene Dendritic Cell Cancer Vaccine Global Market Share (2011-2016)
Table Dendreon Basic Information List
Table Dendreon Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Dendreon Dendritic Cell Cancer Vaccine Global Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Merck Dendritic Cell Cancer Vaccine Global Market Share (2011-2016)
Table Northwest Biotherapeutics Basic Information List
Table Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Global Market Share (2011-2016)
Table Glaxo Smith Kline Basic Information List
Table Glaxo Smith Kline Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Glaxo Smith Kline Dendritic Cell Cancer Vaccine Global Market Share (2011-2016)
Table ImmunoCellular Therapeutics Basic Information List
Table ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Figure ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccine Global Market Share (2011-2016)
Table Tella Incorporation Basic Information List
Table Tella Incorporation Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Tella Incorporation Dendritic Cell Cancer Vaccine Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Dendritic Cell Cancer Vaccine
Figure Manufacturing Process Analysis of Dendritic Cell Cancer Vaccine
Figure Dendritic Cell Cancer Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Dendritic Cell Cancer Vaccine Major Manufacturers in 2015
Table Major Buyers of Dendritic Cell Cancer Vaccine
Table Distributors/Traders List
Figure Global Dendritic Cell Cancer Vaccine Sales and Growth Rate Forecast (2016-2021)
Figure Global Dendritic Cell Cancer Vaccine Revenue and Growth Rate Forecast (2016-2021)
Table Global Dendritic Cell Cancer Vaccine Sales Forecast by Regions (2016-2021)
Table Global Dendritic Cell Cancer Vaccine Sales Forecast by Type (2016-2021)
Table Global Dendritic Cell Cancer Vaccine Sales Forecast by Application (2016-2021)